Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |